Italy Urology Devices Market Overview,2030

The urology devices market in Italy has evolved through a combination of strong medical research, advanced hospital infrastructure, and an increasing preference for minimally invasive surgical techniques. Italian urology has a long academic and clinical tradition, with institutions such as Policlinico Universitario A. Gemelli in Rome and Ospedale San Raffaele in Milan leading innovation in robotic and laser-assisted procedures. The introduction of flexible fiber-optic and digital cystoscopes has transformed diagnostic accuracy, supported by research at the University of Bologna and University of Florence, which have pioneered the use of high-resolution imaging and tele-urology consultations for remote patients. Italy’s aging population, with over 23 percent aged above 65 according to ISTAT, has contributed to higher rates of benign prostatic hyperplasia, kidney disease, and urinary incontinence, driving adoption of both hospital-based and home-use urology devices. The integration of robotic-assisted technologies, particularly the da Vinci surgical system, is now routine in major Italian hospitals for prostate and renal surgeries, while Holmium and Thulium laser systems are standard for lithotripsy and prostate vaporization procedures. The Italian National Health Service, under the Ministry of Health, has emphasized infection control through single-use catheters and disposable endoscopic instruments to minimize cross-contamination risks. AI-enabled diagnostic tools are being developed in collaboration with Politecnico di Milano and Siemens Healthineers to improve prostate cancer detection using MRI-based analytics. Telemedicine platforms like TelMed and Doctorium facilitate virtual follow-ups and chronic urinary management across regions such as Lombardy and Emilia-Romagna. Italian medical device regulations follow European CE certification and ISO quality standards, with strict sterilization and reprocessing guidelines enforced by the Italian Medicines Agency (AIFA). As healthcare sustainability becomes a national focus, hospitals like Ospedale Maggiore Policlinico have introduced recycling programs for reusable tools and eco-friendly packaging initiatives, marking a transition toward safer, cleaner, and digitally connected urological care across Italy.

According to the research report, ""Italy Urology Devices Market Overview, 2030,"" published by Bonafide Research, the Italy Urology Devices market is expected to reach a market size of more than USD 1.56 Billion by 2030. Italy’s urology devices market is witnessing dynamic progress through clinical modernization, strong manufacturer presence, and the growing integration of advanced medical technologies across both public and private hospitals. Major developments include the expansion of outpatient and day-care centers at facilities such as Humanitas Research Hospital in Milan and Policlinico Sant’Orsola-Malpighi in Bologna, where laser lithotripsy, endoscopic stone removal, and transurethral prostate procedures are now performed in same-day surgical units. Robotic surgery adoption has accelerated nationwide, with over 100 da Vinci robotic systems currently operational across Italy, while the Versius robotic platform by CMR Surgical has entered pilot programs at regional hospitals in Naples and Turin. Italy’s domestic manufacturing base is supported by firms such as Siare Engineering and AB Medica, which produce and distribute specialized surgical instruments and endoscopic systems. International manufacturers including Karl Storz, Olympus, and Boston Scientific maintain long-term distribution partnerships with Italian distributors like Gada Italia and Movi SpA, ensuring nationwide access and servicing support. Government-backed reimbursement models under Servizio Sanitario Nazionale (SSN) cover key urological interventions, while supplementary insurers like Unisalute and Generali Italia provide private coverage for minimally invasive procedures. Collaborative research initiatives between the University of Padua and Medtronic have focused on biocompatible materials and nano-coated stents to improve urinary flow and reduce infection risks. Startups such as UroMems Italia are investing in smart implants and AI-based urinary sensors to enhance patient mobility and monitoring. Cold chain logistics and sterile device handling are managed by logistics firms such as DHL Life Sciences Italy to ensure compliance with EU standards. Equipment leasing programs through MediCredit have made advanced robotic and laser systems more accessible for mid-sized hospitals.

In Italy, the urology devices market by type is defined by its advanced medical infrastructure, skilled urology professionals, and strong presence of both European and global manufacturers. The product category includes diagnostic and surgical instruments such as endoscopes, cystoscopes, ureteroscopes, laser and lithotripsy systems, and dialysis devices that are widely used in hospitals like Policlinico Universitario A. Gemelli in Rome and Ospedale San Raffaele in Milan. Italian urology centers have a long history of expertise in minimally invasive surgery, and many have adopted flexible and rigid endoscopes from manufacturers such as Karl Storz and Olympus for routine diagnostic and therapeutic use. Holmium:YAG laser systems are frequently used for stone fragmentation and prostate tissue resection in facilities like Azienda Ospedaliero Universitaria Careggi in Florence. Extracorporeal shock wave lithotripsy devices remain essential for non-invasive stone treatment and are available in regional hospitals throughout northern Italy. Dialysis devices form an integral part of the Italian healthcare system, particularly in nephro-urology departments managing patients with chronic renal failure associated with hypertension or diabetes. The accessories segment encompasses a wide variety of consumables including catheters, ureteral stents, drainage bags, lubricating gels, and single-use surgical tools that support both inpatient and outpatient procedures. Foley and intermittent catheters from brands like B. Braun and Coloplast are standard across Italian hospitals and home-care programs, while ureteral stents are routinely employed to maintain urinary tract patency following stone extraction or surgery. Hydrophilic gels and sterile lubricants are critical for patient safety during catheterization and cystoscopy. Recent initiatives by Italy’s Ministry of Health have emphasized infection control and single-use device adoption, leading to broader use of disposable scopes and sterile accessories. These high-precision instruments and essential consumables illustrates Italy’s balance between technological innovation and patient safety within its urology care framework.

In Italy, the use of urology devices spans multiple clinical applications reflecting both the aging population and the nation’s focus on technologically advanced, patient-centered care. Urolithiasis (stone disease) is a leading application area, particularly prevalent in southern regions like Sicily and Puglia where water mineral content and dietary factors increase kidney stone formation. Hospitals such as Policlinico di Bari and Ospedale Niguarda Ca’ Granda in Milan use flexible ureteroscopes, nephroscopes, and Holmium laser systems to perform minimally invasive stone fragmentation. Benign Prostatic Hyperplasia (BPH) treatments in Italy frequently involve transurethral resection systems, laser vaporization technologies, and minimally invasive implants used in leading urology units like those at Policlinico Sant’Orsola-Malpighi in Bologna. Urological cancers, including prostate, bladder, and kidney cancers, are managed through endoscopic resection tools, biopsy systems, and robotic-assisted surgery platforms such as the da Vinci Surgical System, widely adopted in cancer treatment centers like Istituto Nazionale dei Tumori in Milan. Urinary incontinence and pelvic organ prolapse treatments rely on slings, bulking agents, and artificial urinary sphincters used in specialized urogynecology departments across Rome and Naples. For erectile dysfunction, Italian andrology clinics employ penile implants, injection therapies, and vacuum-assisted devices for patients unresponsive to pharmacological treatments. Kidney diseases drive substantial use of dialysis machines and related consumables in integrated nephrology-urology clinics, especially in hospitals operating under the Italian National Health Service. Other applications include pediatric urology procedures performed in children’s hospitals such as Ospedale Pediatrico Bambino Gesù in Rome, where specialized miniature endoscopes and catheters are employed for managing congenital abnormalities, strictures, and infections. Across Italy, the integration of robotic systems, energy-based tools, and reusable endoscopy platforms has transformed the country’s approach to urological care, emphasizing precision, comfort, and long-term patient outcomes in both public and private healthcare institutions.

In Italy, urology devices are extensively used across hospitals, clinics, dialysis centers, and home care settings, each serving a distinct role in patient management. Hospitals and clinics remain the primary end users, especially large academic and regional hospitals such as Ospedale Maggiore Policlinico in Milan, Policlinico Gemelli in Rome, and Ospedale Santa Chiara in Pisa, where advanced diagnostic and surgical equipment such as cystoscopes, laser lithotripters, and robotic-assisted platforms are used for complex urological procedures. These facilities provide comprehensive services from prostate surgeries and stone treatments to reconstructive and oncological interventions. Private clinics, including Humanitas Research Hospital and Villa Stuart, offer minimally invasive urology procedures using compact laser and endoscopic systems designed for outpatient operations. Dialysis centers form another vital component of Italy’s urological and renal care infrastructure. Facilities operated by Fresenius Medical Care, Diaverum, and local health authorities provide hemodialysis and peritoneal dialysis for patients with chronic kidney disease, integrating urinary catheter systems and fluid management devices to handle overlapping urological complications. Dialysis units in northern regions like Lombardy and Emilia-Romagna are often co-managed with hospital nephrology departments to ensure multidisciplinary treatment. Home care settings in Italy are expanding rapidly as part of the national effort to decentralize chronic disease management and improve patient autonomy. Patients use intermittent catheterization kits, home dialysis machines, and external drainage systems under supervision from home-nursing services such as those coordinated by the Servizio Sanitario Nazionale. Portable medical devices distributed by companies like B. Braun and Coloplast allow patients to maintain mobility and hygiene while receiving ongoing urological care at home. Italy’s healthcare system integrates advanced technologies, infection prevention protocols, and coordinated care models to enhance accessibility, safety, and efficiency in the delivery of urological treatments nationwide.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Urology Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Product
• Accessories

By Application
• Urolithiasis (Stone Disease)
• Benign Prostatic Hyperplasia (BPH)
• Urological Cancers
• Urinary Incontinence & Pelvic Organ Prolapse
• Erectile Dysfunction
• Kidney Diseases
• Other Applications (Pediatrics, Strictures, Infections, etc.)

By End Use
• Hospitals and clinics
• Dialysis centers
• Others (Home care settings) Show more